(Q36968906)

17 August 2017

1 reference

title

Beyond methylphenidate: nonstimulant medications for youth with ADHD. (English)

1 reference

attention deficit hyperactivity disorder

17 August 2017

1 reference

1 reference

Jamie G Wood

1

1 reference

17 August 2017

Jessica L Crager

series ordinal

2

1 reference

17 August 2017

Christopher M Delap

series ordinal

3

1 reference

17 August 2017

Kelly D Heiskell

series ordinal

4

1 reference

17 August 2017

language of work or name

1 reference

1 November 2007

1 reference

Journal of Attention Disorders

17 August 2017

published in

1 reference

17 August 2017

volume

11

1 reference

17 August 2017

issue

3

1 reference

17 August 2017

page(s)

341-350

1 reference

Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Four-year follow-up of children with low intelligence and ADHD: a replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Alpha-2 adrenergic agonists decrease distractibility in aged monkeys performing the delayed response task

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Adolescents with attention-deficit/hyperactivity disorder: an overview of empirically based treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

GW320659 for the treatment of attention-deficit/hyperactivity disorder in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Nontricyclic antidepressants: current trends in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Side effects of desipramine and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Critical review of tricyclic antidepressant use in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Efficacy review of antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Clonidine treatment of Gilles de la Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Nicotine effects on adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Venlafaxine in children and adolescents with attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Carbamazepine side effects in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Psychiatric comorbidities in children with attention deficit hyperactivity disorder: implications for management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Methylphenidate and desipramine in hospitalized children: I. Separate and combined effects on cognitive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Nonstimulant medications in the treatment of attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Carbamazepine use in children and adolescents with features of attention-deficit hyperactivity disorder: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Bupropion effects in attention deficit and conduct disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Nortriptyline treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Stages of faith and identity: birth to teens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Maternal smoking during pregnancy and attention deficit hyperactivity disorder symptoms in offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Treatment of ADHD in children with tics: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Venlafaxine treatment of patients with comorbid alcohol/cocaine abuse and attention-deficit/hyperactivity disorder: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Atomoxetine and nonresponders to stimulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Cardiovascular effects of atomoxetine in children, adolescents, and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Nortriptyline in the treatment of ADHD: a chart review of 58 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054707305968

21 January 2018

Identifiers

DOI

10.1177/1087054707305968

1 reference

17 August 2017

1 reference